TRVI
Trevi Therapeutics Inc.
$10.62
+$0.43(+4.22%)
66
Overall
60
Value
91
Tech
47
Quality
Market Cap
$1.20B
Volume
2.18M
52W Range
$2.36 - $10.16
Target Price
$20.36
Key Metrics Overview
| Market Cap | $1.20B | P/E Ratio | N/A |
| 52W High | $10.16 | 52W Low | $2.36 |
| Div Yield | N/A | Payout Ratio | 0.0% |
| EPS Growth 3Y | N/A | 52W Position | 105.9% |
| Overall Score | 66 | Value Score | 60 |
| Quality Score | 47 | Technical Score | 91 |
Growth Analysis
| EPS Current Est | $-0.39 | EPS Next Est | $-0.54 |
| EPS Growth Est | N/A | DPS Growth 3Y | N/A |
Revenue (5Y)
No data available
EBITDA (5Y)
No data available
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | TRVI | $10.62 | +4.2% | 2.18M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |